2-219501527-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_013335.4(GMPPA):c.190C>T(p.Pro64Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00287 in 1,613,098 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_013335.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GMPPA | NM_013335.4 | c.190C>T | p.Pro64Ser | missense_variant | 4/13 | ENST00000313597.10 | NP_037467.2 | |
ASIC4-AS1 | XR_923921.2 | n.391+15169G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GMPPA | ENST00000313597.10 | c.190C>T | p.Pro64Ser | missense_variant | 4/13 | 1 | NM_013335.4 | ENSP00000315925 | P1 | |
ASIC4-AS1 | ENST00000429882.1 | n.182+15169G>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00220 AC: 335AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00229 AC: 577AN: 251478Hom.: 2 AF XY: 0.00235 AC XY: 319AN XY: 135914
GnomAD4 exome AF: 0.00294 AC: 4301AN: 1460818Hom.: 11 Cov.: 29 AF XY: 0.00285 AC XY: 2074AN XY: 726838
GnomAD4 genome AF: 0.00220 AC: 335AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.00197 AC XY: 147AN XY: 74454
ClinVar
Submissions by phenotype
Alacrima, achalasia, and intellectual disability syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 16, 2022 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital | Apr 19, 2017 | BS1,BP4; This alteration has an allele frequency that is greater than expected for the associated disease, and is predicted to be tolerated by multiple functional prediction tools. - |
GMPPA-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 29, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 01, 2018 | This variant is associated with the following publications: (PMID: 28820871) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at